Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11β-hydroxysteroid dehydrogenase: A model for 11-HSD I deficiency

Clinical Endocrinology

Volumn 43, Issue 5, 1995, Pages 637-644

  Raven, P W ^a   Checkley, S A ^a   Taylor, N F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOREDUCTASE; 11BETA HYDROXYSTEROID DEHYDROGENASE; HYDROCORTISONE; METYRAPONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ENZYME DEFICIENCY; FEMALE; HUMAN; PRIORITY JOURNAL;

EID: 0028850596     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1995.tb02930.x     Document Type: Article

References (0)